Deborah Dunsire

Insider Reports History

Location
Novato, CA
Signature
/s/ Sarah Ahmad Ali, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Deborah Dunsire:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. Director Common Stock 30,815 $1,170,353 $37.98 15 May 2025 Direct
MCKESSON CORP Director Restricted Stock Units (RSUs) 301 $202,741 $580.92 30 Jul 2025 Direct
Syros Pharmaceuticals, Inc. Director Common Stock 12,000 $59,400 $4.95 01 Jun 2024 Direct
Syros Pharmaceuticals, Inc. Director Restricted Stock Units 4,000 $19,800 $4.95 05 Jun 2024 Direct
Ultragenyx Pharmaceutical Inc. Director Stock Option (Right to Buy) 10,787 15 May 2025 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 6,000 05 Jun 2024 Direct
ALEXION PHARMACEUTICALS, INC. Director Common Stock, par value $.0001 per share 0 $177.00 21 Jul 2021 Direct

Insider Reports Filed by Deborah Dunsire

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MCK MCKESSON CORP 30 Jul 2025 1 $0 4 Director 31 Jul 2025, 18:31
RARE Ultragenyx Pharmaceutical Inc. 15 May 2025 2 $0 4 Director 19 May 2025, 18:31
MCK MCKESSON CORP 31 Jul 2024 1 $0 4 Director 01 Aug 2024, 17:40
RARE Ultragenyx Pharmaceutical Inc. 18 Jun 2024 2 $0 4 Director 20 Jun 2024, 14:29
SYRS Syros Pharmaceuticals, Inc. 05 Jun 2024 2 $0 4 Director 07 Jun 2024, 16:30
MCK MCKESSON CORP 03 Jun 2024 1 $0 4 Director 04 Jun 2024, 16:42
MCK MCKESSON CORP 03 Jun 2024 0 $0 3 Director 04 Jun 2024, 16:39
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2024 2 $0 4 Director 04 Jun 2024, 16:42
RARE Ultragenyx Pharmaceutical Inc. 07 Jun 2023 2 $0 4 Director 09 Jun 2023, 14:29
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2023 2 $0 4 Director 02 Jun 2023, 16:23
SYRS Syros Pharmaceuticals, Inc. 16 Sep 2022 2 $0 4 Director 19 Sep 2022, 17:08
RARE Ultragenyx Pharmaceutical Inc. 24 Jun 2022 2 $0 4 Director 28 Jun 2022, 13:48
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2022 1 $0 4 Director 02 Jun 2022, 19:10
SYRS Syros Pharmaceuticals, Inc. 09 Sep 2021 1 $0 4 Director 10 Sep 2021, 17:30
SYRS Syros Pharmaceuticals, Inc. 09 Sep 2021 0 $0 3 Director 10 Sep 2021, 17:27
ALXN ALEXION PHARMACEUTICALS, INC. 21 Jul 2021 1 $0 4 Director 23 Jul 2021, 16:48
RARE Ultragenyx Pharmaceutical Inc. 24 Jun 2021 2 $0 4 Director 28 Jun 2021, 18:25
ALXN ALEXION PHARMACEUTICALS, INC. 20 May 2021 2 $0 4 Director 24 May 2021, 16:27